Yahoo India Web Search

Search results

  1. Divis is a leading manufacturer of Generic APIs, Nutraceutical ingredients and Custom synthesis of APIs for Big Pharma. It operates in Hyderabad, India and offers over 25 products, Carotenoids and Vitamins.

  2. Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. [5] [6] [2] [7] The company manufactures and custom synthesizes generic APIs, intermediates.

  3. DivisLabs is a leading pharmaceutical company with two cGMP API manufacturing units, three R&D centers and a robust quality system. It exports its products to more than 95 countries and has a workforce of over 16,500 employees.

  4. Divis Laboratories, a leading pharmaceutical company, reached a 52-week high on July 5th, 2024, with a 2.5% increase in stock price. The company has consistently outperformed the sector and its moving averages, showing a positive trend. With a 24.10% increase in the past year, Divis Laboratories remains a top choice for investors in the pharma ...

  5. 2 days ago · Discover the Divi's Laboratories Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a top-performing stock. Keep track of Divi's Laboratories's latest details, including: Last traded price 4540.0, Market capitalization: 120682.02, Volume: 518429, Price-to-earnings ratio 75.29, Earnings per share 60.27. Our liveblog offers a holistic view of Divi's Laboratories by examining both fundamental and technical indicators. Stay ahead of market trends with ...

  6. DIVIS LABORATORIES is a leading manufacturer of generic APIs, nutraceutical ingredients and custom synthesis for global markets. Learn about its history, products, locations, employees, updates and events on LinkedIn.

  7. People also ask

  8. 4 days ago · Stay up-to-date with the Divi's Laboratories Stock Liveblog, your trusted source for real-time updates and thorough analysis of a prominent stock. Explore the latest details on Divi's Laboratories, including: Last traded price 4606.35, Market capitalization: 122021.31, Volume: 485911, Price-to-earnings ratio 76.26, Earnings per share 60.27. Get a comprehensive understanding of Divi's Laboratories with our coverage of both fundamental and technical indicators. Stay informed about breaking ...

  1. People also search for